Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has subsequently produced an average ...

Vertex stock has climbed more than 60% over three years.

Krystal Biotech is engaged in developing genetic medicines. The biotech stock is near a buy point with earnings due soon.

The next 12 months will be important for the drugmaker.

Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Ultragenyx Pharmaceuticals reported Phase 3 results for setrusumab, a potential treatment for osteogenesis imperfecta. Several firms have reduced their price targets on Ultragenyx stock. Investors may ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, amid insider sales, slow revenue growth, and weak adoption of its core ...

In this article, we will look at the 11 Best Pharma Stocks to Invest In. CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing. As laid out by the two governments, ...